Compound Summary
Compound Information
Maprotiline hydrochloride
Compound Name: | Maprotiline hydrochloride |
Compound CID: | 71478 |
Synonyms: | Maprotiline hydrochloride 10347-81-6 Maprotiline Hcl Ludiomil Psymion More... |
Iupac Name: | N-methyl-3-(1-tetracyclo[6.6.2.02,7.09,14]hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine;hydrochloride |
InChI: | InChI=1S/C20H23N.ClH/c1-21-14-6-12-20-13-11-15(16-7-2-4-9-18(16)20)17-8-3-5-10-19(17)20;/h2-5,7-10,15,21H,6,11-14H2,1H3;1H |
InChIKey: | NZDMFGKECODQRY-UHFFFAOYSA-N |
Canonical Smiles: | CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24.Cl |
Isomeric Smiles: | CNCCCC12CCC(C3=CC=CC=C31)C4=CC=CC=C24.Cl |
Molecular Weight: | 313.9 |
Molecular Formula: | C20H24ClN |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
Maprotiline hydrochloride
Molecular Weight: | 313.9 |
Molecular Formula: | C20H24ClN |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 1 |
Rotatable Bond Count: | 4 |
Heavy Atom Count: | 22 |
Complexity: | 339 |
Synonyms
Maprotiline hydrochloride
| Maprotiline hydrochloride | Maprotiline hydrochloride |
|---|---|
Maprotiline hydrochloride |
10347-81-6 |
Maprotiline Hcl |
Ludiomil |
Psymion |
Deprilept |
9-(gamma-Methylaminopropyl)-9,10-dihydro-9,10-ethanoanthracene hydrochloride |
Maprotilline HCl |
UNII-7C8J54PVFI |
Maprotiline (hydrochloride) |
Maprotiline, HCl |
Maprotiline Hydrochlorine |
7C8J54PVFI |
MLS000069552 |
MLS000557000 |
N-Methyl-9,10-ethanoanthracene-9(10H)-propanamine hydrochloride |
3-(9,10-ethanoanthracen-9(10H)-yl)-N-methylpropan-1-amine hydrochloride |
MFCD00079464 |
SMR000058834 |
SMR000148117 |
1-(3-Methylaminopropyl)dibenzo(b,e)bicyclo(2.2.2)octadiene hydrochloride |
Ciba 34276 Ba |
1-(3-MethylaMinopropyl)dibenzob,ebicyclo2.2.2octadienehydrochloride;1-(3-MethylaMinopropyl)dibenzob,ebicyclo2.2.2octadienehydrochloride |
SR-01000076016 |
EINECS 233-758-8 |
CAS-10347-81-6 |
BA 34276 |
MaprotilineHCl |
Ludiomil HCl |
1-(3-methylaminopropyl)dibenzob,ebicyclo2.2.2octadiene hydrochloride |
9,10-Ethanoanthracene-9(10H)-propanamine, N-methyl-, hydrochloride |
Ludiomil (TN) |
Prestwick_749 |
Maprotiline hydrochloride USP:JAN |
CPD000148117 |
Opera_ID_513 |
N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine hydrochloride |
Opera_ID_1466 |
DSSTox_CID_24507 |
DSSTox_RID_80277 |
LUDIOMIL HYDROCHLORIDE |
DSSTox_GSID_44507 |
MLS000758284 |
MLS001148189 |
MLS001423998 |
SCHEMBL121014 |
SPECTRUM1500373 |
REGID_for_CID_71478 |
CHEBI:6691 |
CHEMBL1200427 |
CHEMBL1237135 |
DTXSID2044507 |
Maprotiline HCl;Ludiomil;Psymion |
HMS1569E13 |
HMS1920J13 |
KUC112481C |
Pharmakon1600-01500373 |
Maprotiline, Ludiomil Hydrochloride |
BCP23366 |
HY-B0444 |
STR09724 |
Tox21_300992 |
Tox21_500812 |
9,10-Ethanoanthracene-9(10H)-propylamine, N-methyl-, hydrochloride |
CCG-38957 |
NSC757085 |
s2517 |
AKOS015961872 |
AKOS015994755 |
Maprotiline hydrochloride (JP17/USP) |
AC-8249 |
BCP9000894 |
CCG-220346 |
KS-5095 |
LP00812 |
NC00056 |
NSC 757085 |
NSC-757085 |
NCGC00094145-01 |
NCGC00094145-02 |
NCGC00094145-03 |
NCGC00094145-04 |
NCGC00254894-01 |
NCGC00261497-01 |
BM164655 |
KSC-315-031- |
BCP0726000234 |
AB0012620 |
EU-0100812 |
FT-0659758 |
M2527 |
SW196892-3 |
D00818 |
M 9651 |
T71539 |
Maprotiline hydrochloride, >99% (HPLC), powder |
347M816 |
A907819 |
SR-01000000134 |
J-000980 |
SR-01000000134-3 |
SR-01000076016-1 |
SR-01000076016-3 |
Q27268058 |
Maprotiline Hydrochloride 1.0 mg/ml in Methanol (as free base) |
Maprotiline hydrochloride, European Pharmacopoeia (EP) Reference Standard |
Maprotiline hydrochloride, United States Pharmacopeia (USP) Reference Standard |
Hydron;N-methyl-3-(1-tetracyclo6.6.2.02,7.09,14hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine;chloride |
Maprotiline hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material |
methyl(3-{tetracyclo6.6.2.0(2),?.0?,(1)?hexadeca-2,4,6,9,11,13-hexaen-1-yl}propyl)amine hydrochloride |
N-methyl-3-(1-tetracyclo6.6.2.02,7.09,14hexadeca-2,4,6,9,11,13-hexaenyl)propan-1-amine;hydrochloride |
Experimental Data
Maprotiline hydrochloride
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | 10 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
Maprotiline hydrochloride
Statistics Data
Maprotiline hydrochloride
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 10 | 1 | 1 |
Statistics Data Visualization
Maprotiline hydrochloride
